FDA Expands HPV Primary Screening Options - Quiz - MDSpire

FDA Expands HPV Primary Screening Options

Regulatory action broadens available approaches for cervical cancer screening in US clinical practice.

  • By

  • Kathryn Wighton

  • February 4, 2026

  • 2 min

Share

Original Source(s)

FDA Expands HPV Primary Screening Options

  • by Kathryn Wighton

  • February 4, 2026

Related Content

FDA Monthly Preview: Key July Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

FDA Approves New First-Line TNBC Regimen

Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.

Differences in Cascade Genetic Testing Among Families With Hereditary Cancer Risk